BioProcess Operator
Help produce recombinant laminins that support cell research. Join BioLamina’s production team, where careful bioprocessing, teamwork, and quality make a difference.
BioLamina is looking for skilled, well-organized, and meticulous BioProcess Operators for our two production sites. If you are looking for a position in a fast-paced biotechnology industry, we are inviting you to apply.
You will be part of the production team, producing human recombinant laminins that are supplied to customers to support culturing platforms for different types of primary cells. To meet ISO 9001 and QMS criteria, the manufacturing is carried out in compliance with defined processes, established procedures, and relevant laws and regulations.
Main tasks and responsibilities
The BioProcess Operator actively participates in production areas for which training and certification has been received, working both individually and in teams. Responsibility for tasks are assigned under the department areas.
• Production of recombinant proteins according to written procedures: Adherent and suspension cell processes, upstream/midstream operations, media preparations, equipment handling and cleaning, material handling.
• Documentation of activities according to QMS by recording events in, for example, BPRs and logbooks, as well as reporting of unexpected events in applicable reports.
• Identify and participate in deviation investigations, Corrective and Preventive Actions (CAPA) and Change Control activities.
• Update Standard Operating Procedures (SOPs).
• Responsibility of equipment
Qualifications
• Higher Vocational Education (YH utbildning) and/or a minimum of 2 years working experience as a Process Operator, in the chemical, biotech or pharmaceutical industry.
• Alternatively, a laboratory science background and/or previous experience of working within upstream/midstream or downstream processing.
• Basic computer skills, Word and Excel.
• Proficiency in written and spoken English.
Merit if you have
• Experience with cell culture and/or chromatographic purification.
• Experience in biotechnological production of recombinant proteins, aseptic working technique, and cleanrooms.
• Experience of large-scale production process.
• Experience of working according to ISO 9001 and/or GMP.
• Swedish language.
Personal Skills
We are looking for an individual that works well independently and as part of a team. You are a solid team member who is reliable and has great interpersonal skills. You plan and perform your own work in accordance with department prioritization and goals and are an active contributor to the continuous development of the department and company.
- Department
- Production
- Locations
- Flemingsberg, Sundbyberg
Current job openings
Perks & Benefits
-
A secure employment and benefits from the collective agreement
Occupational pension, work-related accident insurance,
-
Parental leave compensation
Approx. 10 percent of the employee´s monthly salary
-
Health and wellness initiatives
-
Newly renovated premises in great location and equal ergonomic workstations.
-
Working time reduction
Workplace and culture
“Working together, building on each other’s ideas and knowledge, creates greatness. I am proud that we are unpretentious, curious, and fearless enough to dare to approach and talk to people often more talented than we to build new partnerships. These abilities have helped us to find new ways forward through collaborations.”
Therése Kallur, PhD
CSO, VP Business Development
About BioLamina AB
BioLamina is a biotechnology company with a scientific base and heritage in matrix biology and cell culture research. It supports scientists who have struggled for decades to grow pluripotent stem cells and other primary cells in the lab. By providing tools for efficient and easy cell culture, BioLamina aims to ease the path towards safe and effective cell therapies and make better cell assays and models for increasing accuracy in drug discovery and development. The power of Biolaminin® substrates, developed by BioLamina, has been demonstrated in numerous publications, and they will continue to provide vital support to the stem cell community, from scientific concepts to clinical studies.